Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients

Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients

The visceral adiposity index (VAI) is a marker of visceral fat distribution and dysfunction. Visceral adiposity is related to non-alcoholic fatty liver disease (NAFLD); however, there is some controversy regarding the association between VAI and NAFLD. The aim of this study was to analyse the relati...

Full description

Bibliographic Details
Main Authors:	Rubén Díez-Rodríguez, María Dolores Ballesteros-Pomar, Alicia Calleja-Fernández, Tomás González-De-Francisco, Luis González-Herráez, Sara Calleja-Antolín, Isidoro Cano-Rodríguez, José Luis Olcoz-Goñi
Format:	Article
Language:	English
Published:	Aran Ediciones 2014-12-01
Series:	Revista Espanola de Enfermedades Digestivas
Subjects:	Abdominal obesity Non-alcoholic steatohepatitis Fatty liver
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082014000800004&lng=en&tlng=en

Similar Items

Efectos de la pérdida de peso mediante una dieta muy baja en calorías (VLCD) sobre la pérdida de peso tras derivación biliopancreática en pacientes con obesidad severa
by: M. D. Ballesteros Pomar, et al.
Published: (2013-02-01)

Usefulness of an index score as a predictor of hepatic fibrosis in obese patients undergoing bariatric surgery Utilidad de un índice de puntuación como predictor de fibrosis hepática en pacientes obesos sometidos a cirugía bariátrica
by: R. Díez Rodríguez, et al.
Published: (2009-08-01)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
by: Sadatsugu Sakane, et al.
Published: (2021-01-01)

The applicability of the Visceral Adiposity Index (VAI) for predicting visceral fat
by: Nadja Fernandes da Silva, et al.
Published: (2023-02-01)

GRADING SCALE OF VISCERAL ADIPOSE TISSUE THICKNESS AND THEIR RELATION TO THE NONALCOHOLIC FATTY LIVER DISEASE
by: Luís Jesuino de Oliveira ANDRADE, et al.
Published: (2014-04-01)

Association of visceral adiposity and insulin resistance with colorectal adenoma and colorectal cancer
by: In Sub Jung, et al.
Published: (2019-07-01)

Relationship between visceral adiposity and hypertension
by: Mariana Felgueira Pavanelli, et al.
Published: (2013-02-01)

Apolipoprotein B Levels Predict Future Development of Hypertension Independent of Visceral Adiposity and Insulin Sensitivity
by: Seung Jin Han, et al.
Published: (2020-06-01)

Cuestionario semicuantitativo para la valoración de la ingesta dietética del paciente hospitalizado: una herramienta sencilla para la práctica clínica
by: Alicia Calleja Fernández, et al.

Genetic and Environmental Factors Contributing to Visceral Adiposity in Asian Populations
by: Rachel Williams, et al.
Published: (2020-12-01)

Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index
by: Xueyu Chen, et al.
Published: (2022-03-01)

Development of Visceral and Subcutaneous-Abdominal Adipose Tissue in Breastfed Infants during First Year of Lactation
by: Zoya Gridneva, et al.
Published: (2021-09-01)

Applicability of the visceral adiposity index (VAI) in predicting components of metabolic syndrome in young adults
by: Jéssica Schuster, et al.

The determination of cut-off points of the visceral adiposity index in predicting metabolic syndrome, insulin resistance, diabetes mellitus, and hypertension
by: Selma Pekgör, et al.
Published: (2022-05-01)

Visceral Adipose Tissue and Different Measures of Adiposity in Different Severities of Diffuse Idiopathic Skeletal Hyperostosis
by: Netanja I. Harlianto, et al.
Published: (2021-07-01)

Association between Blood Mercury Level and Visceral Adiposity in Adults
by: Jong Suk Park, et al.
Published: (2017-01-01)

Visceral adiposity index and prognosis among patients with ischemic heart failure
by: Patrícia Vogel, et al.

Expression of LONP1 Is High in Visceral Adipose Tissue in Obesity, and Is Associated with Glucose and Lipid Metabolism
by: Ju Hee Lee, et al.
Published: (2021-06-01)

Relationship of Visceral Adipose Tissue With Dilated Perivascular Spaces
by: Yunli Qi, et al.
Published: (2021-02-01)

The Connection between MicroRNAs from Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease
by: Veronika Zubáňová, et al.
Published: (2021-04-01)

Prolonged fasting with fluid therapy is related to poorer outcomes in medical patients
by: Georgios Kyriakos, et al.
Published: (2013-10-01)

Adipocitos, obesidad visceral, inflamación y enfermedad cardiovascular Adipocytes, visceral obesity, inflammation and cardiovascular disease
by: Fernando Manzur, et al.
Published: (2010-09-01)

Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
by: Stephen D. H. Malnick, et al.
Published: (2022-12-01)

Visceral adiposity, insulin resistance and cancer risk
by: Donohoe Claire L, et al.
Published: (2011-06-01)

Visceral Adiposity and Diet Quality Are Differentially Associated With Cognitive Abilities and Early Academic Skills Among Preschool-Age Children
by: Naiman A. Khan, et al.
Published: (2020-01-01)

Association of visceral adiposity index with incident nephropathy and retinopathy: a cohort study in the diabetic population
by: Zhiyuan Wu, et al.
Published: (2022-02-01)

Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease
by: Ilkay S. Idilman, et al.
Published: (2021-06-01)

Possible Amelioration of the Severity of Nutritional Steatohepatitis by Guggulsterone in Mice
by: Sara Ameen Nafeer, et al.
Published: (2019-06-01)

Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis
by: Cristina Alarcón-Vila, et al.
Published: (2023-02-01)

An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients
by: Pathik Parikh, et al.
Published: (2016-01-01)

Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis[S]
by: George N. Ioannou, et al.
Published: (2013-05-01)

Influence of Visceral Adiposity on Cardiovascular Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus
by: Eun-Hee Jang, et al.
Published: (2012-08-01)

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-12-01)

Novel Asian-Specific Visceral Adiposity Indices Are Associated with Chronic Kidney Disease in Korean Adults
by: Jonghwa Jin, et al.
Published: (2023-05-01)

The Value of Abdominal Visceral Adipose Tissue Area and Homeostasis Model Assessment of Insulin Resistance in Predicting Essential Hypertension Complicated with Obstructive Sleep Apnea Syndrome
by: GAN Lulu, HE Yan, LIU Shijie, NI Qing, YANG Li
Published: (2022-01-01)

Abdominal Visceral Adipose Tissue and All-Cause Mortality: A Systematic Review
by: Randa K. Saad, et al.
Published: (2022-08-01)

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
by: Stephen Caldwell
Published: (2017-06-01)

Visceral adipose tissue area measured by computed tomography is correlated with recurrence and severity of hyperlipidemic acute pancreatitis
by: GUO Yan, et al.
Published: (2019-07-01)

Avaliação por imagem da área de gordura visceral e suas correlações com alterações metabólicas Evaluación por imagen del área de grasa visceral y sus correlaciones con alteraciones metabólicas Imaging assessment of visceral adipose tissue area and its correlations with metabolic alterations
by: Anna Karla Carneiro Roriz, et al.
Published: (2010-12-01)

Lipid accumulation product and visceral adiposity index for incidence of cardiovascular diseases and mortality; results from 13 years follow‐up in Isfahan cohort study
by: Mohammad Fakhrolmobasheri, et al.
Published: (2024-02-01)